Altanta, GA 4/26/12 (StreetBeat) -- EPIC Corporation (Pinksheets: EPOR) introduced AcuFab and AcuPad brand names for the EPIC Spacer Fabric and EPIC Sleep Pad. The Company also confirmed that shareholders of record on April 27, 2012 will receive a 100% stock dividend and an in-kind divided of a single EPIC Sleep Pad.
AcuFab is the brand name for the EPIC Spacer Fabric from which EPIC is producing several healthcare products. The AcuFab is a therapeutic knitted fabric with concave and convex channels that provides ventilation and circulation.
AcuPad is the brand name for EPIC's sleep pads, pressure overlays, wheelchair pads, seat pads, and auto and truck seat pads for consumers and healthcare institutions. The AcuPad products are designed to help prevent pressure sores, lower back pain, increased circulation of air and blood, reduce stress, decrease muscle tension and stiffness, and much more.
The Company has declared a 100% stock dividend and is giving a twin bed size Sleep Pad to all shareholders of record on April 27, 2012. Each shareholder will receive a voucher in the mail and must return it to the Company with full contact information to receive the twin size pad. The voucher will give the shareholder a twin size Sleep Pad free and the right to purchase a double, queen or California king size Sleep Pad at the current sales price of $123.28 for the twin bed size plus $15 for shipping and handling.
EPIC's mission is to provide people with better healthcare. Visit www.epiccor.com for corporate and investor information.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.
StreetBeat Disclaimer
No comments:
Post a Comment